{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:56:48Z","timestamp":1787021808837,"version":"build-2736575974"},"update-to":[{"DOI":"10.1371\/journal.pmed.1004422","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T00:00:00Z","timestamp":1722211200000}}],"reference-count":79,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T00:00:00Z","timestamp":1721001600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009553","name":"Agentura Pro Zdravotnick\u00fd V\u00fdzkum \u010cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["NU22-D-146"],"award-info":[{"award-number":["NU22-D-146"]}],"id":[{"id":"10.13039\/501100009553","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009553","name":"Agentura Pro Zdravotnick\u00fd V\u00fdzkum \u010cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["NU22-D-146"],"award-info":[{"award-number":["NU22-D-146"]}],"id":[{"id":"10.13039\/501100009553","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009553","name":"Agentura Pro Zdravotnick\u00fd V\u00fdzkum \u010cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["NU22-D-146"],"award-info":[{"award-number":["NU22-D-146"]}],"id":[{"id":"10.13039\/501100009553","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009553","name":"Agentura Pro Zdravotnick\u00fd V\u00fdzkum \u010cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["NU22-D-146"],"award-info":[{"award-number":["NU22-D-146"]}],"id":[{"id":"10.13039\/501100009553","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009553","name":"Agentura Pro Zdravotnick\u00fd V\u00fdzkum \u010cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["NU22-D-146"],"award-info":[{"award-number":["NU22-D-146"]}],"id":[{"id":"10.13039\/501100009553","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003243","name":"Ministerstvo Zdravotnictv\u00ed Cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["00023752"],"award-info":[{"award-number":["00023752"]}],"id":[{"id":"10.13039\/501100003243","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003243","name":"Ministerstvo Zdravotnictv\u00ed Cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["00023752"],"award-info":[{"award-number":["00023752"]}],"id":[{"id":"10.13039\/501100003243","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003243","name":"Ministerstvo Zdravotnictv\u00ed Cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["00023752"],"award-info":[{"award-number":["00023752"]}],"id":[{"id":"10.13039\/501100003243","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003243","name":"Ministerstvo Zdravotnictv\u00ed Cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["00023752"],"award-info":[{"award-number":["00023752"]}],"id":[{"id":"10.13039\/501100003243","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003243","name":"Ministerstvo Zdravotnictv\u00ed Cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["00023752"],"award-info":[{"award-number":["00023752"]}],"id":[{"id":"10.13039\/501100003243","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosmedicine.org"],"crossmark-restriction":false},"short-container-title":["PLoS Med"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Evidence suggests reduced survival rates following Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection in people with preexisting mental disorders, especially psychotic disorders, before the broad introduction of vaccines. It remains unknown whether this elevated mortality risk persisted at later phases of the pandemic and when accounting for the confounding effect of vaccination uptake and clinically recorded physical comorbidities.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Methods and findings<\/jats:title>\n                    <jats:p>We used data from Czech national health registers to identify first-ever serologically confirmed SARS-CoV-2 infections in 5 epochs related to different phases of the pandemic: 1st March 2020 to 30th September 2020, 1st October 2020 to 26th December 2020, 27th December 2020 to 31st March 2021, 1st April 2021 to 31st October 2021, and 1st November 2021 to 29th February 2022. In these people, we ascertained cases of mental disorders using 2 approaches: (1) per the International Classification of Diseases 10th Revision (ICD-10) diagnostic codes for substance use, psychotic, affective, and anxiety disorders; and (2) per ICD-10 diagnostic codes for the above mental disorders coupled with a prescription for anxiolytics\/hypnotics\/sedatives, antidepressants, antipsychotics, or stimulants per the Anatomical Therapeutic Chemical (ATC) classification codes. We matched individuals with preexisting mental disorders with counterparts who had no recorded mental disorders on age, sex, month and year of infection, vaccination status, and the Charlson Comorbidity Index (CCI). We assessed deaths with Coronavirus Disease 2019 (COVID-19) and from all-causes in the time period of 28 and 60 days following the infection using stratified Cox proportional hazards models, adjusting for matching variables and additional confounders. The number of individuals in matched-cohorts ranged from 1,328 in epoch 1 to 854,079 in epoch 5. The proportion of females ranged from 34.98% in people diagnosed with substance use disorders in epoch 3 to 71.16% in individuals diagnosed and treated with anxiety disorders in epoch 5. The mean age ranged from 40.97 years (standard deviation [SD] = 15.69 years) in individuals diagnosed with substance use disorders in epoch 5 to 56.04 years (SD = 18.37 years) in people diagnosed with psychotic disorders in epoch 2. People diagnosed with or diagnosed and treated for psychotic disorders had a consistently elevated risk of dying with COVID-19 in epochs 2, 3, 4, and 5, with adjusted hazard ratios (aHRs) ranging from 1.46 [95% confidence intervals (CIs), 1.18, 1.79] to 1.93 [95% CIs, 1.12, 3.32]. This patient group demonstrated also a consistently elevated risk of all-cause mortality in epochs 2, 3, 4, and 5 (aHR from 1.43 [95% CIs, 1.23, 1.66] to 1.99 [95% CIs, 1.25, 3.16]). The models could not be reliably fit for psychotic disorders in epoch 1. People diagnosed with substance use disorders had an increased risk of all-cause mortality 28 days postinfection in epoch 3, 4, and 5 (aHR from 1.30 [95% CIs, 1.14, 1.47] to 1.59 [95% CIs, 1.19, 2.12]) and 60 days postinfection in epoch 2, 3, 4, and 5 (aHR from 1.22 [95% CIs, 1.08, 1.38] to 1.52 [95% CIs, 1.16, 1.98]). Cases ascertained based on diagnosis of substance use disorders and treatment had increased risk of all-cause mortality in epoch 2, 3, 4, and 5 (aHR from 1.22 [95% CIs, 1.03, 1.43] to 1.91 [95% CIs, 1.25, 2.91]). The models could not be reliably fit for substance use disorders in epoch 1. In contrast to these, people diagnosed with anxiety disorders had a decreased risk of death with COVID-19 in epoch 2, 3, and 5 (aHR from 0.78 [95% CIs, 0.69, 0.88] to 0.89 [95% CIs, 0.81, 0.98]) and all-cause mortality in epoch 2, 3, 4, and 5 (aHR from 0.83 [95% CIs, 0.77, 0.90] to 0.88 [95% CIs, 0.83, 0.93]). People diagnosed and treated for affective disorders had a decreased risk of both death with COVID-19 and from all-causes in epoch 3 (aHR from 0.87 [95% CIs, 0.79, 0.96] to 0.90 [95% CIs, 0.83, 0.99]), but demonstrated broadly null effects in other epochs. Given the unavailability of data on a number of potentially influential confounders, particularly body mass index, tobacco smoking status, and socioeconomic status, part of the detected associations might be due to residual confounding.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>People with preexisting psychotic, and, less robustly, substance use disorders demonstrated a persistently elevated risk of death following SARS-CoV-2 infection throughout the pandemic. While it cannot be ruled out that part of the detected associations is due to residual confounding, this excess mortality cannot be fully explained by lower vaccination uptake and more clinically recorded physical comorbidities in these patient groups.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pmed.1004422","type":"journal-article","created":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T13:43:54Z","timestamp":1721051034000},"page":"e1004422","update-policy":"https:\/\/doi.org\/10.1371\/journal.pmed.corrections_policy","source":"Crossref","is-referenced-by-count":17,"title":["Deaths with COVID-19 and from all-causes following first-ever SARS-CoV-2 infection in individuals with preexisting mental disorders: A national cohort study from Czechia"],"prefix":"10.1371","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6740-6860","authenticated-orcid":true,"given":"Tom\u00e1\u0161","family":"Form\u00e1nek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Libor","family":"Poto\u010d\u00e1r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0295-8848","authenticated-orcid":true,"given":"Katrin","family":"Wolfova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-4422-9455","authenticated-orcid":true,"given":"Hana","family":"Melicharov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karol\u00edna","family":"Mlad\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0766-1624","authenticated-orcid":true,"given":"Anna","family":"Wiedemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danni","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavel","family":"Mohr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7244-0051","authenticated-orcid":true,"given":"Petr","family":"Winkler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0387-880X","authenticated-orcid":true,"given":"Peter B.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1400-0111","authenticated-orcid":true,"given":"Ji\u0159\u00ed","family":"Jarkovsk\u00fd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2024,7,15]]},"reference":[{"issue":"18","key":"pmed.1004422.ref001","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1056\/NEJMoa1915784","article-title":"Association between Mental Disorders and Subsequent Medical Conditions","volume":"382","author":"NC Momen","year":"2020","journal-title":"N Engl J Med"},{"issue":"23\u201324","key":"pmed.1004422.ref002","first-page":"405","article-title":"Mortality and medical comorbidity in the severely mentally ill\u2014a German registry study.","volume":"116","author":"F Schneider","year":"2019","journal-title":"Dtsch Arztebl Int"},{"issue":"2","key":"pmed.1004422.ref003","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1001\/jamapsychiatry.2015.2688","article-title":"Association of Mental Disorders With Subsequent Chronic Physical Conditions: World Mental Health Surveys From 17 Countries.","volume":"73","author":"KM Scott","year":"2016","journal-title":"JAMA Psychiatry"},{"issue":"10211","key":"pmed.1004422.ref004","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1016\/S0140-6736(19)32316-5","article-title":"A comprehensive analysis of mortality-related health metrics associated with mental disorders: a nationwide, register-based cohort study","volume":"394","author":"O Plana-Ripoll","year":"2019","journal-title":"Lancet"},{"key":"pmed.1004422.ref005","article-title":"Changes Over Time in the Differential Mortality Gap in Individuals With Mental Disorders","author":"O Plana-Ripoll","year":"2020","journal-title":"JAMA Psychiatry"},{"issue":"10","key":"pmed.1004422.ref006","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/S2215-0366(22)00237-1","article-title":"All-cause and cause-specific mortality among people with severe mental illness in Brazil\u2019s public health system, 2000\u201315: a retrospective study","volume":"9","author":"APS Melo","year":"2022","journal-title":"Lancet Psychiatry"},{"issue":"3","key":"pmed.1004422.ref007","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0152223","article-title":"Excess Mortality in Patients with Severe Mental Disorders in 1996\u20132010 in Finland.","volume":"11","author":"S Lumme","year":"2016","journal-title":"PLoS ONE."},{"issue":"1","key":"pmed.1004422.ref008","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/wps.20806","article-title":"Increased risk of COVID-19 infection and mortality in people with mental disorders: analysis from electronic health records in the United States.","volume":"20","author":"Q Wang","year":"2021","journal-title":"World Psychiatry."},{"issue":"4","key":"pmed.1004422.ref009","doi-asserted-by":"crossref","first-page":"e227287","DOI":"10.1001\/jamanetworkopen.2022.7287","article-title":"Association of Psychiatric Disorders With Incidence of SARS-CoV-2 Breakthrough Infection Among Vaccinated Adults","volume":"5","author":"K Nishimi","year":"2022","journal-title":"JAMA Netw Open"},{"key":"pmed.1004422.ref010","first-page":"32","article-title":"COVID-19 risk, course and outcome in people with mental disorders: a systematic review and meta-analyses.","author":"JD Blom","year":"2023","journal-title":"Epidemiol Psychiatr Sci"},{"issue":"11","key":"pmed.1004422.ref011","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.34969","article-title":"Analysis of COVID-19 Infection and Mortality Among Patients With Psychiatric Disorders, 2020","volume":"4","author":"AL Teixeira","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"6","key":"pmed.1004422.ref012","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1192\/bjp.2020.251","article-title":"Association of mental disorders with SARS-CoV-2 infection and severe health outcomes: nationwide cohort study.","volume":"218","author":"H-L Jeon","year":"2021","journal-title":"Br J Psychiatry"},{"issue":"2","key":"pmed.1004422.ref013","doi-asserted-by":"crossref","first-page":"e69","DOI":"10.1016\/S2666-7568(20)30013-1","article-title":"Pre-pandemic psychiatric disorders and risk of COVID-19: a UK Biobank cohort analysis","volume":"1","author":"H Yang","year":"2020","journal-title":"Lancet Healthy Longev"},{"issue":"7","key":"pmed.1004422.ref014","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.1038\/s41380-022-01562-2","article-title":"COVID-19 and severe mental illness in Israel: testing, infection, hospitalization, mortality and vaccination rates in a countrywide study","volume":"27","author":"N Goldberger","year":"2022","journal-title":"Mol Psychiatry"},{"issue":"4","key":"pmed.1004422.ref015","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1001\/jamapsychiatry.2020.4442","article-title":"Association of Psychiatric Disorders With Mortality Among Patients With COVID-19","volume":"78","author":"K Nemani","year":"2021","journal-title":"JAMA Psychiatry"},{"issue":"1","key":"pmed.1004422.ref016","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1001\/jamapsychiatry.2022.3614","article-title":"Preexisting Neuropsychiatric Conditions and Associated Risk of Severe COVID-19 Infection and Other Acute Respiratory Infections","volume":"80","author":"TA Ranger","year":"2022","journal-title":"JAMA Psychiatry"},{"issue":"1","key":"pmed.1004422.ref017","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1186\/s12888-024-05629-y","article-title":"COVID-19-associated mortality in individuals with serious mental disorders in Sweden during the first two years of the pandemic\u2013a population-based register study.","volume":"24","author":"A Gibbs","year":"2024","journal-title":"BMC Psychiatry"},{"key":"pmed.1004422.ref018","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.jpsychires.2022.08.019","article-title":"Association between mental disorders and COVID-19 outcomes among inpatients in France: A retrospective nationwide population-based study","volume":"155","author":"A Descamps","year":"2022","journal-title":"J Psychiatr Res"},{"issue":"3","key":"pmed.1004422.ref019","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1093\/pubmed\/fdaa241","article-title":"Association of substance use disorders and drug overdose with adverse COVID-19 outcomes in New York City: January\u2013October 2020.","volume":"43","author":"B Allen","year":"2021","journal-title":"J Public Health"},{"issue":"1","key":"pmed.1004422.ref020","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41380-020-00880-7","article-title":"COVID-19 risk and outcomes in patients with substance use disorders: analyses from electronic health records in the United States","volume":"26","author":"QQ Wang","year":"2021","journal-title":"Mol Psychiatry"},{"issue":"12","key":"pmed.1004422.ref021","article-title":"Assessing the risk of COVID-19 reinfection and severe outcomes among individuals with substance use disorders: a retrospective study using real-world electronic health records","volume":"13","author":"T Wen-Jan","year":"2023","journal-title":"BMJ Open"},{"issue":"2","key":"pmed.1004422.ref022","doi-asserted-by":"crossref","first-page":"e1004134","DOI":"10.1371\/journal.pmed.1004134","article-title":"Mental disorders, COVID-19-related life-saving measures and mortality in France: A nationwide cohort study.","volume":"20","author":"M Schwarzinger","year":"2023","journal-title":"PLoS Med."},{"key":"pmed.1004422.ref023","first-page":"85","article-title":"COVID-19 vaccination, incidence, and mortality rates among individuals with mental disorders in South Korea: A nationwide retrospective study.","author":"D-W Lee","year":"2023","journal-title":"Asian J Psychiatr."},{"key":"pmed.1004422.ref024","author":"T Form\u00e1nek","year":"2023","journal-title":"COVID-19 and All-cause Mortality following First-ever SARS-CoV-2 Infection in Individuals with Pre-existing Mental Disorders: A National Cohort Study from Czechia"},{"issue":"4","key":"pmed.1004422.ref025","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1192\/S2056474000001446","article-title":"State of mental healthcare systems in Eastern Europe: do we really understand what is going on?","volume":"13","author":"D Krupchanka","year":"2016","journal-title":"BJPsych Int."},{"issue":"8","key":"pmed.1004422.ref026","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/S2215-0366(17)30135-9","article-title":"A blind spot on the global mental health map: a scoping review of 25 years\u2019 development of mental health care for people with severe mental illnesses in central and eastern Europe","volume":"4","author":"P Winkler","year":"2017","journal-title":"Lancet Psychiatry"},{"issue":"1","key":"pmed.1004422.ref027","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1192\/bji.2017.27","article-title":"Mental health reforms in the Czech Republic","volume":"16","author":"O. Pec","year":"2019","journal-title":"BJPsych Int"},{"issue":"1","key":"pmed.1004422.ref028","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s11126-019-09688-3","article-title":"Expenditures on Mental Health Care in the Czech Republic in 2015.","volume":"91","author":"HM Broulikova","year":"2020","journal-title":"Psychiatry Q."},{"key":"pmed.1004422.ref029","volume-title":"Psychiatric Care 2016.","author":"B Nechansk\u00e1","year":"2017"},{"key":"pmed.1004422.ref030","author":"Ministry of Health of the Czech Republic","year":"2013","journal-title":"Stratefy of the Reform of Psychiatric Care."},{"key":"pmed.1004422.ref031","author":"M Komenda","year":"2020","journal-title":"COVID-19: Overview of the Current Situation in Czechia Prague: Ministry of Health of the Czech Republic"},{"key":"pmed.1004422.ref032","author":"Ministry of Health of the Czech Republic","year":"2020","journal-title":"COVID-19 Vaccination Strategy in Czech Republic."},{"issue":"5","key":"pmed.1004422.ref033","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1001\/jamapsychiatry.2014.16","article-title":"A Comprehensive Nationwide Study of the Incidence Rate and Lifetime Risk for Treated Mental Disorders","volume":"71","author":"CB Pedersen","year":"2014","journal-title":"JAMA Psychiatry"},{"issue":"4","key":"pmed.1004422.ref034","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1111\/j.1541-0420.2011.01619.x","article-title":"A New Criterion for Confounder Selection","volume":"67","author":"TJ VanderWeele","year":"2011","journal-title":"Biometrics"},{"issue":"3","key":"pmed.1004422.ref035","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s10654-019-00494-6","article-title":"Principles of confounder selection","volume":"34","author":"TJ VanderWeele","year":"2019","journal-title":"Eur J Epidemiol"},{"issue":"5","key":"pmed.1004422.ref036","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation","volume":"40","author":"ME Charlson","year":"1987","journal-title":"J Chronic Dis"},{"key":"pmed.1004422.ref037","author":"Office for National Statistics.","year":"2021","journal-title":"Coronavirus and mortality in England and Wales methodology"},{"issue":"14","key":"pmed.1004422.ref038","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1001\/jama.2020.1267","article-title":"Why Test for Proportional Hazards?","volume":"323","author":"MJ Stensrud","year":"2020","journal-title":"JAMA"},{"issue":"2","key":"pmed.1004422.ref039","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1080\/00031305.2016.1154108","article-title":"The ASA Statement on p-Values: Context, Process, and Purpose.","volume":"70","author":"RL Wasserstein","year":"2016","journal-title":"Am Stat."},{"key":"pmed.1004422.ref040","volume-title":"R: A language and environment for statistical computing.","author":"R Core Team","year":"2024"},{"issue":"5","key":"pmed.1004422.ref041","doi-asserted-by":"crossref","DOI":"10.1097\/EDE.0000000000000864","article-title":"Web Site and R Package for Computing E-values.","volume":"29","author":"MB Mathur","year":"2018","journal-title":"Epidemiology."},{"issue":"1","key":"pmed.1004422.ref042","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-19478-2","article-title":"Collider bias undermines our understanding of COVID-19 disease risk and severity.","volume":"11","author":"GJ Griffith","year":"2020","journal-title":"Nat Commun."},{"issue":"4","key":"pmed.1004422.ref043","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1287\/isre.2013.0480","article-title":"Too Big to Fail: Large Samples and the p-Value Problem.","volume":"24","author":"M Lin","year":"2013","journal-title":"Inf Syst Res."},{"issue":"4","key":"pmed.1004422.ref044","doi-asserted-by":"crossref","first-page":"268","DOI":"10.7326\/M16-2607","article-title":"Sensitivity Analysis in Observational Research: Introducing the E-Value","volume":"167","author":"TJ VanderWeele","year":"2017","journal-title":"Ann Intern Med"},{"issue":"2","key":"pmed.1004422.ref045","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1093\/schbul\/sbac118","article-title":"Heightened COVID-19 Mortality in People With Severe Mental Illness Persists After Vaccination: A Cohort Study of Greater Manchester Residents.","volume":"49","author":"L Hassan","year":"2023","journal-title":"Schizophr Bull."},{"issue":"2","key":"pmed.1004422.ref046","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1001\/jamapsychiatry.2013.278","article-title":"Cancer-Related Mortality in People With Mental Illness","volume":"70","author":"S Kisely","year":"2013","journal-title":"JAMA Psychiatry"},{"issue":"6","key":"pmed.1004422.ref047","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.genhosppsych.2015.06.003","article-title":"Cancer survival in the context of mental illness: a national cohort study","volume":"37","author":"R Cunningham","year":"2015","journal-title":"Gen Hosp Psychiatry"},{"issue":"6","key":"pmed.1004422.ref048","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/acps.13017","article-title":"Undiagnosed cardiovascular disease prior to cardiovascular death in individuals with severe mental illness.","volume":"139","author":"IH Heiberg","year":"2019","journal-title":"Acta Psychiatr Scand"},{"issue":"3","key":"pmed.1004422.ref049","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1017\/S2045796012000571","article-title":"Emergency department staff views and experiences on diagnostic overshadowing related to people with mental illness.","volume":"22","author":"A Van Nieuwenhuizen","year":"2013","journal-title":"Epidemiol Psychiatr Sci"},{"issue":"9","key":"pmed.1004422.ref050","doi-asserted-by":"crossref","first-page":"e683","DOI":"10.1016\/S2468-2667(21)00160-2","article-title":"Socioeconomic position and the COVID-19 care cascade from testing to mortality in Switzerland: a population-based analysis","volume":"6","author":"J Riou","year":"2021","journal-title":"Lancet Public Health"},{"issue":"1","key":"pmed.1004422.ref051","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1186\/s12889-022-13388-2","article-title":"Socioeconomic and immigration status and COVID-19 testing in Toronto, Ontario: retrospective cross-sectional study.","volume":"22","author":"B O\u2019Neill","year":"2022","journal-title":"BMC Public Health"},{"issue":"3","key":"pmed.1004422.ref052","doi-asserted-by":"crossref","first-page":"e048020","DOI":"10.1136\/bmjopen-2020-048020","article-title":"Association between socioeconomic status and self-reported, tested and diagnosed COVID-19 status during the first wave in the Northern Netherlands: a general population-based cohort from 49 474 adults","volume":"11","author":"Z Yinjie","year":"2021","journal-title":"BMJ Open"},{"issue":"6545","key":"pmed.1004422.ref053","first-page":"eabg5298","article-title":"Socioeconomic status determines COVID-19 incidence and related mortality in Santiago","volume":"372","author":"GE Mena","year":"2021","journal-title":"Chile. Science"},{"issue":"10","key":"pmed.1004422.ref054","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0224127","article-title":"Socioeconomic status and alcohol use disorders across the lifespan: A co-relative control study.","volume":"14","author":"S Calling","year":"2019","journal-title":"PLoS ONE"},{"issue":"7","key":"pmed.1004422.ref055","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1111\/add.15336","article-title":"Association between poverty exposure during childhood and adolescence, and drug use disorders and drug-related crimes later in life.","volume":"116","author":"H Manhica","year":"2021","journal-title":"Addiction."},{"issue":"6","key":"pmed.1004422.ref056","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1093\/schbul\/sbm032","article-title":"Socioeconomic Status at Birth Is Associated With Risk of Schizophrenia: Population-Based Multilevel Study.","volume":"33","author":"S Werner","year":"2007","journal-title":"Schizophr Bull."},{"issue":"9","key":"pmed.1004422.ref057","article-title":"Individual-level and area-level socioeconomic status (SES) and schizophrenia: cross-sectional analyses using the evidence from 1.9 million Chinese adults.","volume":"9","author":"L Yanan","year":"2019","journal-title":"BMJ Open"},{"issue":"1","key":"pmed.1004422.ref058","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1176\/appi.ps.201200143","article-title":"Cigarette Smoking Among Persons With Schizophrenia or Bipolar Disorder in Routine Clinical Settings, 1999\u20132011.","volume":"64","author":"F Dickerson","year":"2013","journal-title":"Psychiatr Serv."},{"key":"pmed.1004422.ref059","first-page":"10","article-title":"Low Physical Activity and Cardiorespiratory Fitness in People With Schizophrenia: A Comparison With Matched Healthy Controls and Associations With Mental and Physical Health.","author":"TW Scheewe","year":"2019","journal-title":"Front Psych."},{"issue":"1","key":"pmed.1004422.ref060","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S2215-0366(19)30416-X","article-title":"Comparative effects of 18 antipsychotics on metabolic function in patients with schizophrenia, predictors of metabolic dysregulation, and association with psychopathology: a systematic review and network meta-analysis","volume":"7","author":"T Pillinger","year":"2020","journal-title":"Lancet Psychiatry"},{"issue":"1","key":"pmed.1004422.ref061","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/wps.20699","article-title":"20-year follow-up study of physical morbidity and mortality in relationship to antipsychotic treatment in a nationwide cohort of 62,250 patients with schizophrenia (FIN20).","volume":"19","author":"H Taipale","year":"2020","journal-title":"World Psychiatry"},{"issue":"5","key":"pmed.1004422.ref062","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1001\/archgenpsychiatry.2011.1532","article-title":"Polypharmacy With Antipsychotics, Antidepressants, or Benzodiazepines and Mortality in Schizophrenia.","volume":"69","author":"J Tiihonen","year":"2012","journal-title":"Arch Gen Psychiatry"},{"issue":"3","key":"pmed.1004422.ref063","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/wps.20060","article-title":"Non-adherence to medication in patients with psychotic disorders: epidemiology, contributing factors and management strategies.","volume":"12","author":"JM Kane","year":"2013","journal-title":"World Psychiatry."},{"key":"pmed.1004422.ref064","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.jpsychires.2021.02.008","article-title":"Behavioural responses and anxiety symptoms during the coronavirus disease 2019 (COVID-19) pandemic in Japan: A large scale cross-sectional study.","volume":"136","author":"G Cai","year":"2021","journal-title":"J Psychiatr Res"},{"key":"pmed.1004422.ref065","doi-asserted-by":"crossref","first-page":"102323","DOI":"10.1016\/j.janxdis.2020.102323","article-title":"Anxiety and safety behavior usage during the COVID-19 pandemic: The prospective role of contamination fear.","volume":"77","author":"KA Knowles","year":"2021","journal-title":"J Anxiety Disord"},{"issue":"1","key":"pmed.1004422.ref066","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1186\/s12879-021-06536-3","article-title":"Mortality-related risk factors of COVID-19: a systematic review and meta-analysis of 42 studies and 423,117 patients.","volume":"21","author":"ZG Dessie","year":"2021","journal-title":"BMC Infect Dis"},{"issue":"1","key":"pmed.1004422.ref067","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/osp4.148","article-title":"Obesity and healthcare resource utilization: comparative results from the UK and the USA.","volume":"4","author":"E N\u00f8rtoft","year":"2018","journal-title":"Obes Sci Pract"},{"issue":"3","key":"pmed.1004422.ref068","doi-asserted-by":"crossref","first-page":"e140","DOI":"10.1016\/S2468-2667(19)30248-8","article-title":"Association between socioeconomic status and the development of mental and physical health conditions in adulthood: a multi-cohort study","volume":"5","author":"M Kivim\u00e4ki","year":"2020","journal-title":"Lancet Public Health"},{"issue":"6","key":"pmed.1004422.ref069","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1007\/s00038-013-0452-7","article-title":"Disparities in health care utilization by smoking status in Canada.","volume":"58","author":"S Azagba","year":"2013","journal-title":"Int J Public Health"},{"issue":"5","key":"pmed.1004422.ref070","doi-asserted-by":"crossref","first-page":"691","DOI":"10.2105\/AJPH.89.5.691","article-title":"The impact of smoking, alcohol consumption, and physical activity on use of hospital services.","volume":"89","author":"N Haapanen-Niemi","year":"1999","journal-title":"Am J Public Health."},{"issue":"2","key":"pmed.1004422.ref071","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000002467","article-title":"Body Mass Index Trajectories and Healthcare Utilization in Young and Middle-aged Adults.","volume":"95","author":"MY Elrashidi","year":"2016","journal-title":"Medicine."},{"issue":"3","key":"pmed.1004422.ref072","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s11136-015-1112-6","article-title":"Smoking status and health-related quality of life: a longitudinal study in young adults.","volume":"25","author":"J Tian","year":"2016","journal-title":"Qual Life Res"},{"issue":"23","key":"pmed.1004422.ref073","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.2174\/138161210792062920","article-title":"Cigarette Smoking and Hypertension.","volume":"16","author":"A Virdis","year":"2010","journal-title":"Curr Pharm Des"},{"issue":"6","key":"pmed.1004422.ref074","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1161\/CIRCRESAHA.116.305697","article-title":"Obesity-Induced Hypertension.","volume":"116","author":"JE Hall","year":"2015","journal-title":"Circ Res"},{"issue":"21","key":"pmed.1004422.ref075","first-page":"e984","article-title":"Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association","volume":"143","author":"TM Powell-Wiley","year":"2021","journal-title":"Circulation"},{"issue":"3","key":"pmed.1004422.ref076","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1177\/2047487318806658","article-title":"Tobacco smoking and the risk of heart failure: A systematic review and meta-analysis of prospective studies","volume":"26","author":"D Aune","year":"2019","journal-title":"Eur J Prev Cardiol"},{"issue":"1","key":"pmed.1004422.ref077","doi-asserted-by":"crossref","first-page":"103","DOI":"10.2307\/2530647","article-title":"The Bias Due to Incomplete Matching","volume":"41","author":"PR Rosenbaum","year":"1985","journal-title":"Biometrics"},{"issue":"1","key":"pmed.1004422.ref078","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s12016-022-08921-5","article-title":"Risk and Protective Factors for COVID-19 Morbidity, Severity, and Mortality.","volume":"64","author":"J-j Zhang","year":"2023","journal-title":"Clin Rev Allergy Immunol"},{"key":"pmed.1004422.ref079","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jclinepi.2022.05.021","article-title":"Avoiding overadjustment bias in social epidemiology through appropriate covariate selection: a primer.","volume":"149","author":"A van Zwieten","year":"2022","journal-title":"J Clin Epidemiol"}],"updated-by":[{"DOI":"10.1371\/journal.pmed.1004422","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T00:00:00Z","timestamp":1722211200000}}],"container-title":["PLOS Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pmed.1004422","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T15:41:28Z","timestamp":1722267688000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pmed.1004422"}},"subtitle":[],"editor":[{"given":"Alexander C.","family":"Tsai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2024,7,15]]},"references-count":79,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2024,7,15]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pmed.1004422","relation":{},"ISSN":["1549-1676"],"issn-type":[{"value":"1549-1676","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,15]]}}}